From: Serious infections in JIA patients upon MTX, TFN inhibitors and combinations
Variable | univariate | HR (CI) | multivarite | HR (CI) |
ADA / MTX | p=0.022 | 7.28(1.32-40.04) | p00.019 | 10.06(1.67-60.67) |
ETA / MTX | p=0.001 | 5.96 (2.03-17.48) | p=0.013 | 4.88(1.39-17.08) |
More than 1 DMARD failure | p=0.006 | 3.06 (1.39-6.75) | Â | Â |
Pretreatment with steroids | p=0.007 | 3.02(1.34-6.77) | Â | Â |
Steroids at baseline | p=0.026 | 0.418 (0.19-0.90) | Â | Â |
MTX concomitant | p=0.001 | 5.54(2.08-14.71) | Â | Â |
JADAS baseline | p=0.004 | 1.09 (1.03-1.16) | Â | Â |
Mean JADAS-level | p<0.001 | 1.12(1.05-1.19) | p<0.001 | 1.12(1.05-1.19) |